Summary
The livestock genomics testing market was valued at $1,533.4 million in 2024 and is estimated to reach $3,691.4 million by 2034, exhibiting a CAGR of 9.3% from 2025 to 2034.
Livestock genomics testing refers to the application of genomic tools and techniques to analyze the makeup of farm animals thereby. This process helps in identifying desirable traits such as disease resistance, growth rate, reproduction efficiency, and product quality, enabling breeders and farmers to make informed breeding genetic decisions. The technology has been increasingly adopted across the livestock sector, including cattle, poultry, swine, and sheep, due to its potential to enhance productivity, improve animal health, and ensure sustainable livestock management. Livestock genomics testing includes whole genome sequencing, genotyping, DNA/RNA analysis, and marker-assisted selection.
Rise in demand for high-quality animal products such as meat, milk, and eggs, along with increase in awareness among farmers about genetic improvement programs, drives the growth of the livestock genomics testing market. Advancements in DNA sequencing technologies and reduced testing costs have made genomic testing more accessible to small and medium-scale livestock producers. Furthermore, governments and agricultural bodies in several countries promote genetic research and offer funding for livestock programs. Surge in need for disease-resistant and climate-resilient breeds, particularly in the face of changing environmental improvement conditions, fosters market growth.
However, high initial costs associated with genomic infrastructure and testing equipment are barrier for widespread adoption of livestock genomics testing, especially in developing regions. In addition, lack of technical expertise and limited awareness about genomics among small-scale farmers hinder market growth. Concerns around data privacy and genetic information misuse also pose challenges to broader acceptance of genomics testing in livestock.
Increase in investment in agri-genomics research, particularly in emerging economies, offers significant opportunities for market growth. Integration of advanced technologies such as AI, bioinformatics, and big data analytics in genomics platforms is expected to enhance predictive capabilities and accelerate breeding cycles. Furthermore, collaborations among academic institutions, biotech firms, and livestock producers are expected to expand the availability of customized testing solutions. As the demand for sustainable and ethical animal farming grows, genomic testing is poised to become a critical tool in optimizing productivity while minimizing environmental impact, thereby unlocking new market potential. For instance, in September 2024, Neogen Corporation teamed up with Genetics Australia to develop a data-informed dairy breeding program focused on milk yield, fertility, and sustainability.
Segment Review
The livestock genomics testing market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into genotyping services, whole genome sequencing (WGS), trait testing, genomic selection (GEBV), embryo testing, disease gene screening, and others. (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Australia and rest of LAMEA).
Key Findings
On the basis of type, the genotyping services segment was the major revenue contributor in 2024.
On the basis of application, the selective breeding segment was the major revenue contributor in 2024.
Region-wise, North America generated the highest revenue in 2024.
Competition Analysis
Major key players that operate in the global livestock genomics testing market are Neogen Corporation, Genus Plc, Illumina, Inc., Zoetis Genetics, Semex Alliance, Agresearch Limited, CRV, Easy DNA, Animal Genetics and XytoVet.
Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Criss-cross segment analysis- market size and forecast
● Expanded list for Company Profiles
● SWOT Analysis
Key Market Segments
By Test Type
● Embryo Testing
● Disease Gene Screening
● Others
● Genotyping Services
● Whole Genome Sequencing (WGS)
● Trait Testing
● Genomic Selection (gEBV)
By Application
● Selective Breeding
● Productivity Enhancement
● Food Safety
● Disease Resistance
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Russia
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ UAE
○ Argentina
○ Rest of LAMEA
● Key Market Players
○ Neogen Corporation
○ Illumina, Inc.
○ Genus Plc
○ Semex alliance
○ CRV Holding B.V.
○ Easy DNA
○ Animal Genetics, Inc.
○ XytoVet
○ Zoetis Genetics
○ Agresearch Limited
ページTOPに戻る
Table of Contents
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low to moderate threat of new entrants
3.3.3. Low to moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in livestock farming and animal husbandry
3.4.1.2. Government and private sector support
3.4.1.3. Focus on disease resistance and health
3.4.2. Restraints
3.4.2.1. High cost of genomic testing technologies
3.4.3. Opportunities
3.4.3.1. Technological advancements
CHAPTER 4: LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Genotyping Services
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Whole Genome Sequencing (WGS)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Trait Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Genomic Selection (gEBV)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Embryo Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Disease Gene Screening
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Others
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
CHAPTER 5: LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Selective Breeding
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Productivity Enhancement
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Food Safety
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Disease Resistance
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: LIVESTOCK GENOMICS TESTING MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Test Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Test Type
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Test Type
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Test Type
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Test Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Test Type
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Test Type
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Test Type
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Test Type
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Test Type
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Russia
6.3.4.6.1. Market size and forecast, by Test Type
6.3.4.6.2. Market size and forecast, by Application
6.3.4.7. Rest of Europe
6.3.4.7.1. Market size and forecast, by Test Type
6.3.4.7.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Test Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Test Type
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Market size and forecast, by Test Type
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Test Type
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Market size and forecast, by Test Type
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Market size and forecast, by Test Type
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Test Type
6.4.4.6.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Test Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Test Type
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. South Africa
6.5.4.2.1. Market size and forecast, by Test Type
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. Saudi Arabia
6.5.4.3.1. Market size and forecast, by Test Type
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. UAE
6.5.4.4.1. Market size and forecast, by Test Type
6.5.4.4.2. Market size and forecast, by Application
6.5.4.5. Argentina
6.5.4.5.1. Market size and forecast, by Test Type
6.5.4.5.2. Market size and forecast, by Application
6.5.4.6. Rest of LAMEA
6.5.4.6.1. Market size and forecast, by Test Type
6.5.4.6.2. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2024
CHAPTER 8: COMPANY PROFILES
8.1. Neogen Corporation
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Genus Plc
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Illumina, Inc.
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Zoetis Genetics
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Semex alliance
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.6. Agresearch Limited
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. CRV Holding B.V.
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.8. Easy DNA
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Animal Genetics, Inc
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. XytoVet
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
